SXTCNasdaqPharmaceutical PreparationsFiscal year ends March 31
China SXT Pharmaceuticals, Inc.
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 1, 2026
$0.11+0.05 (+71.08%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Debt
Borrowings on the balance sheet, Mar 31, 2026
Total debt
$999.57K
$355.18K due within a year
Net debt
-$27.18M
After $28.18M of cash
Implied interest rate
6.97%
FY2026 interest ÷ average debt
Interest coverage
-113.1×
FY2026 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
Bond issues
Individual notes and bonds outstanding
Bond-level data is not connected yet
Coupon, maturity and amount of each note will come from the debt footnote in China SXT Pharmaceuticals's annual report. Trading prices and yields need FINRA TRACE data.